Browse by Audience
Skip to content
Papers of the Week
IVIg-induced headache: prospective study of a large cohort with neurological disorders.
Authors
Hasırcı Bayır BR, Ünsal MA, Ağırcan C, Cerrahoğlu Şirin T, Akan O, Gürsoy G, Eyigürbüz T, Mermi Dibek D, Akdağ G, Elmalı AD, Nazlı E, Akkoyun Arıkan F, Alpaydın Baslo S, Ağırcan D, Oguz-Akarsu E, Ertürk Çetin Ö, Gesoğlu Demir T, Acıman Demirel E, Vurallı D, Deveci Ş, Tanyel T, Mayda Domaç F, Karlı N, Velioğlu S, Baykan BAbstract
Intravenous immune globulin (IVIg) is frequently used in some neurological diseases and is also the first-line therapy in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. We aimed to evaluate the frequency and characteristics of headaches, which is one of the most common side effects of IVIg treatment.